Skip to main content
NewslettersWatchlist

Gsk Plc(GLAXF)
OTC US

Today's Change
Delayed Last Update

Latest News

FILE PHOTO: Novo Nordisk logo is seen in Bagsvaerd outside of Copenhagen, Denmark February 1, 2017. Scanpix Denmark/Liselotte Sabroe via REUTERS ATTENTION EDITORS - THIS IMAGE WAS PROVIDED BY A THIRD PARTY. FOR EDITORIAL USE ONLY. DENMARK OUT. NO COMMERCIAL OR EDITORIAL SALES IN DENMARK./File Photo
Ozempic maker Novo Nordisk bulks up on weight loss drugs, buying Montreal’s Inversago for $1-billion
The Globe and Mail - Thu Aug 10, 2023
The Globe and Mail
Thu Aug 10, 2023
Inversago acquisition is the latest in series of $1-billion takeovers of Canadian life-science companies and will be a win for investors in the country
Roberto Bellini, President and CEO of Bellus Health Inc. The drug developer’s shares rose by as much as 75 per cent after Bellus, chaired by former BioChem chief executive officer Francesco Bellini and led by his son Roberto, reported positive results from a trial involving 310 people. Handout/Bellus Health Inc.
GSK’s $2-billion purchase of Bellus delivers second big exit for Montreal’s Bellini family
The Globe and Mail - Tue Apr 18, 2023
The Globe and Mail
Tue Apr 18, 2023
Deal comes 22 years and multiple setbacks after sale of BioChem Pharma for $5.9-billion

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).